MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
attributable to fulgent
-$60,513K
(-41.69%↓ Y/Y)
Net loss
attributable to...
-$1,118K
(-0.54%↓ Y/Y)
Net loss from
consolidated operations
-$61,631K
(-40.65%↓ Y/Y)
(benefit from) provision
for income taxes
-$8,394K
(-3.17%↓ Y/Y)
Interest income
$30,919K
(-1.23%↓ Y/Y)
Clinical Institutional
Contracts
$184,601K
(19.30%↑ Y/Y)
Clinical Insurance
Contracts
$130,253K
(5.11%↑ Y/Y)
Clinical Patient
Contracts
$7,817K
(62.41%↑ Y/Y)
Other income, net
$153K
(-72.73%↓ Y/Y)
Loss before income
taxes
-$70,025K
(-34.78%↓ Y/Y)
Total other income,
net
$21,071K
(-4.06%↓ Y/Y)
Revenue
$322,671K
(13.83%↑ Y/Y)
Impairment loss
$9,926K
Interest expense
$75K
(144.12%↑ Y/Y)
Operating loss
-$91,096K
(-23.24%↓ Y/Y)
Gross profit
$130,875K
(22.07%↑ Y/Y)
Cost of revenue
$191,796K
(8.82%↑ Y/Y)
Total operating
expenses
$221,971K
(22.55%↑ Y/Y)
General and
administrative
$116,664K
(32.41%↑ Y/Y)
Research and development
$53,905K
(10.42%↑ Y/Y)
Selling and marketing
$43,371K
(19.66%↑ Y/Y)
Amortization of intangible
assets
$8,031K
(0.83%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Fulgent Genetics, Inc. (FLGT)
Fulgent Genetics, Inc. (FLGT)